Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Tactile Systems Technology (TCMD) Research & Development (2016 - 2026)

Tactile Systems Technology has reported Research & Development over the past 12 years, most recently at $2.8 million for Q1 2026.

  • Quarterly Research & Development rose 59.45% to $2.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $9.5 million through Mar 2026, up 12.88% year-over-year, with the annual reading at $8.5 million for FY2025, 3.97% down from the prior year.
  • Research & Development was $2.8 million for Q1 2026 at Tactile Systems Technology, up from $2.5 million in the prior quarter.
  • Over five years, Research & Development peaked at $2.8 million in Q1 2026 and troughed at $1.5 million in Q1 2022.
  • The 5-year median for Research & Development is $2.0 million (2024), against an average of $2.1 million.
  • Year-over-year, Research & Development decreased 18.76% in 2025 and then surged 59.45% in 2026.
  • A 5-year view of Research & Development shows it stood at $2.1 million in 2022, then decreased by 16.18% to $1.8 million in 2023, then increased by 13.66% to $2.0 million in 2024, then rose by 24.19% to $2.5 million in 2025, then grew by 9.68% to $2.8 million in 2026.
  • Per Business Quant, the three most recent readings for TCMD's Research & Development are $2.8 million (Q1 2026), $2.5 million (Q4 2025), and $2.2 million (Q3 2025).